NSF Logo.png

Superior Nano Receives Phase I SBIR-NSF Grant to Develop Msorb® Nanoparticles as Vehicles for Poorly Bioavailable Drugs

June 17, 2022

TWO HARBORS, MINNESOTA – Superior Nano LLC has been awarded a $256,000 Small Business Innovation Research (SBIR) grant from the National Science Foundation to research Dense Nanolipid Fluids (DNLFs) as vehicles for administering drugs with poor bioavailability.  The grant will allow Superior Nano to synthesize drug containing DNLFs for drug property evaluation with collaborators at the University of Minnesota, Case Western Reserve University, and the NIH National Center for Advancing Translational Sciences (NCATS). The importance of encapsulating drugs in patented Msorb® DNLFs is increasing drug bioavailability by better absorption through skin and linings of the digestive tract.

  

“NSF accelerates the translation of emerging technologies into transformative new products and services,” said Erwin Gianchandani, NSF Assistant Director for Technology, Innovation and Partnerships. “We take great pride in funding deep-technology startups and small businesses that will shape science and engineering results into meaningful solutions for today and tomorrow.”

  

The heart of the Superior Nano technology is a twin screw extruder, the type of machine used to make bulk items such as plastic parts, films, fibers, cloth and foods. Whereas other methods of making nanos struggle to produce a pound of nanos in an afternoon, the extruder at Superior Nano’s Two Harbors facility yields a pound of pure nanos every two minutes, free from traces of contaminating chemicals or harsh solvents. The innovative, cutting edge Msorb® technology has been perfected at Superior through creation and development of super bioavailable skin care serums including favorites nanoFirm, nanoLuminous and Daytime Radiance.

 

Brian Garhofer, CEO

Superior Nano

info@superiornano.com